PTH suppression by calcitriol does not predict off‐target actions in experimental CKD

Abstract Vitamin D receptor agonist (VDRA) therapy for PTH suppression is a mainstay for patients with severe CKD. Calcitriol (1,25‐(OH)2D3) is a former first‐line VDRA in CKD treatment. However, a consequence of its use in CKD is accelerated vascular calcification (VC). An experimental CKD model wa...

Olles dieđut

Furkejuvvon:
Bibliográfalaš dieđut
Váldodahkkit: Bruno A. Svajger (Dahkki), Cynthia M. Pruss (Dahkki), Kimberly J. Laverty (Dahkki), Jason G. E. Zelt (Dahkki), Glenville Jones (Dahkki), Martin Kaufmann (Dahkki), Martin Petkovich (Dahkki), Rachel M. Holden (Dahkki), Michael A. Adams (Dahkki)
Materiálatiipa: Girji
Almmustuhtton: Wiley, 2020-06-01T00:00:00Z.
Fáttát:
Liŋkkat:Connect to this object online.
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Interneahtta

Connect to this object online.

3rd Floor Main Library

oažžasuvvan: 3rd Floor Main Library
Hildobáiki: A1234.567
Njađus 1 Oažžumis